Status:
NO_LONGER_AVAILABLE
Compassionate Use of Vidutolimod
Lead Sponsor:
Regeneron Pharmaceuticals
Conditions:
Refractory Melanoma
Eligibility:
All Genders
Brief Summary
Provide Compassionate Use of Vidutolimob
Detailed Description
Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.
Eligibility Criteria
Inclusion
- \-
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06063746
Last Update
January 8 2026
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.